Combined Lung-Liver and Delayed Kidney Transplantation for Cystic Fibrosis Clinical Approach and Outcome: A Case Report

Transplant Proc. 2020 Nov;52(9):2824-2826. doi: 10.1016/j.transproceed.2020.02.154. Epub 2020 May 7.

Abstract

Reports on the long-term outcomes and immunosuppressive regimens of multiorgan transplant patients are limited. Here, we describe a patient with cystic fibrosis complicated by multiorgan failure who was successfully treated with combined liver lung transplant and delayed kidney transplant, resulting in excellent outcomes. Delayed kidney transplant was done to reduce the operative stress of a single procedure, giving time for adequate resuscitation and weaning from vasopressors. Our patient's postoperative course was complicated by post-transplant lymphoproliferative disease, which was successfully treated with rituximab and reduced dosages of immunosuppression.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cystic Fibrosis / surgery*
  • Humans
  • Immunologic Factors / therapeutic use
  • Kidney Transplantation / adverse effects
  • Kidney Transplantation / methods*
  • Liver Transplantation / adverse effects
  • Liver Transplantation / methods*
  • Lung Transplantation / adverse effects
  • Lung Transplantation / methods*
  • Lymphoproliferative Disorders / drug therapy
  • Lymphoproliferative Disorders / etiology
  • Male
  • Postoperative Complications / drug therapy
  • Postoperative Complications / etiology
  • Rituximab / therapeutic use

Substances

  • Immunologic Factors
  • Rituximab